Prenetics Global (PRENW) Stock Price, News & Analysis

Company Overview

Prenetics Global Limited is a Hong Kong-based health sciences company focused on genomics, precision oncology and early cancer detection. Founded in 2014 by Danny Yeung, the company develops and commercializes genetic testing and health-information products intended to support preventive care, personalized wellness and clinical decision-making.

Its consumer health business includes CircleDNA, a direct-to-consumer genetic testing platform that provides reports related to ancestry, wellness, nutrition, fitness and disease risk. Prenetics also operates in clinical genomics through ACT Genomics, which provides tumor-profiling and other genomic testing services designed to help healthcare professionals evaluate cancer treatment options.

Prenetics has expanded its focus to early cancer detection through Insighta, a company developing blood-based technologies intended to identify cancer at earlier stages. The group serves customers and healthcare organizations across markets including Asia, the United Kingdom and the United States, and is led by founder and Chief Executive Officer Danny Yeung. Prenetics became a publicly traded company in the United States in 2022.

Key Stats

• Today's Range: $0.0099 to $0.0099
• 50-Day Range: $0.0081 to $0.0143
• 52-Week Range: $0.01 to $0.04
• Volume: 4 shs
• Average Volume: 44,739 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/03/2026
• Next Earnings (Estimated): 11/05/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NASDAQ:PRENW
• CIK: 1876431
• Web: www.prenetics.com
• Phone: 852 2210 9588
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $154.59 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A